Study: NCT02833831

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALS-008176
Description: Participants will receive a single dose of ALS-008176 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching Placebo will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Participants will receive a single dose of moxifloxacin 400 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Participants will receive a single dose of moxifloxacin 400 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Participants will receive a single dose of moxifloxacin 400 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Participants will receive a single dose of moxifloxacin 400 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Participants will receive a single dose of moxifloxacin 400 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Participants will receive a single dose of moxifloxacin 400 mg.